Your browser doesn't support javascript.
Impact of SARS-CoV-2 pandemic among health care workers in a secondary teaching hospital in Spain.
Garralda Fernandez, Javier; Molero Vilches, Ignacio; Bermejo Rodríguez, Alfredo; Cano Torres, Isabel; Colino Romay, Elda Isabel; García Arata, Isabel; Jaqueti Aroca, Jerónimo; Lillo Rodríguez, Rosa; López Lacomba, Daniel; Mazón Cuadrado, Luis; Molina Esteban, Laura; Morales García, Luis Javier; Moratilla Monzo, Laura; Nieto-Borrajo, Elva; Pacheco Delgado, María; Prieto Menchero, Santiago; Sánchez Hernández, Cristina; Sánchez Testillano, Eva; García-Martínez, Jesús.
  • Garralda Fernandez J; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Molero Vilches I; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Bermejo Rodríguez A; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Cano Torres I; Health Sciences Faculty, Universidad Rey Juan Carlos, Madrid, Spain.
  • Colino Romay EI; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • García Arata I; Occupational Health Service, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Jaqueti Aroca J; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Lillo Rodríguez R; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • López Lacomba D; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Mazón Cuadrado L; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Molina Esteban L; Occupational Health Service, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Morales García LJ; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Moratilla Monzo L; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Nieto-Borrajo E; Health Sciences Faculty, Universidad Rey Juan Carlos, Madrid, Spain.
  • Pacheco Delgado M; Preventive Medicine Service, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Prieto Menchero S; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Sánchez Hernández C; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • Sánchez Testillano E; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
  • García-Martínez J; Laboratory Medicine, Hospital Universitario de Fuenlabrada, Fuenlabrada, Spain.
PLoS One ; 16(1): e0245001, 2021.
Article in English | MEDLINE | ID: covidwho-1028628
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

The COVID-19 pandemic has posed a huge challenge to healthcare systems and their personnel worldwide. The study of the impact of SARS-CoV-2 infection among healthcare workers (HCW), through prevalence studies, will let us know viral expansion, individuals at most risk and the most exposed areas in healthcare organizations. The aim of this study is to gauge the impact of SARS-CoV-2 pandemic in our hospital workforce and identify groups and areas at increased risk. METHODS AND

FINDINGS:

This is a cross-sectional and incidence study carried out on healthcare workers based on molecular and serological diagnosis of SARS-CoV-2 infection. Of the 3013 HCW invited to participate, 2439 (80.9%) were recruited, including 674 (22.4%) who had previously consulted at the Occupational Health Service (OHS) for confirmed exposure and/or presenting symptoms suggestive of COVID-19. A total of 411 (16.9%) and 264 (10.8%) healthcare workers were SARS-CoV-2 IgG and rRT-PCR positive, respectively. The cumulative prevalence considering all studies (IgG positive HCW and/or rRT-PCR positive detection) was 485 (19.9%). SARS-CoV-2 IgG-positive patients in whom the virus was not detected were 221 (9.1%); up to 151 of them (68.3%) did not report any compatible symptoms nor consult at the OHS for this reason. Men became more infected than women (25% vs 18.5%, p = 0.0009), including when data were also classified by age. COVID-19 cumulative prevalence among the HCW assigned to medical departments was higher (25.2%) than others, as well as among medical staff (25.4%) compared with other professional categories (p<0.01).

CONCLUSIONS:

The global impact of the COVID-19 pandemic on HCW of our centre has been 19.9%. Doctors and medical services personnel have had the highest prevalence of SARS-CoV-2 infection, but many of them have not presented compatible symptoms. This emphasizes the performance of continuous surveillance methods of the most exposed health personnel and not only based on the appearance of symptoms.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0245001

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Health Personnel / COVID-19 Type of study: Cohort study / Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: PLoS One Journal subject: Science / Medicine Year: 2021 Document Type: Article Affiliation country: Journal.pone.0245001